SCHEMBL4694969

SCHEMBL4694969

Cc1ccc(C(CC(N)=O)N2CC3CN(C(=O)c4ccc(F)c(F)c4F)CC3C2)cc1Cl

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 8/20 0.38
HCRTR2 O43614 8/20 0.38
HPGD P15428 2/20 0.38
USP2 O75604 1/20 0.38
TNF P01375 1/20 0.35
KCNK3 O14649 1/20 0.33
KCNK9 Q9NPC2 1/20 0.33
P2RX7 Q99572 2/20 0.33
DPP4 P27487 1/20 0.33
DPP8 Q6V1X1 1/20 0.33
DPP9 Q86TI2 1/20 0.33
DPP7 Q9UHL4 1/20 0.33
TACR3 P29371 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4694165 0.92 HCRTR1 (0.48) HCRTR1HCRTR2HPGDTNFKCNK3
SCHEMBL4694375 0.89 HCRTR1 (0.40) HCRTR1HCRTR2HPGDUSP2TNF
SCHEMBL4692944 0.89 HCRTR1 (0.41) HCRTR1HCRTR2KCNK3KCNK9P2RX7
SCHEMBL4692712 0.89 HCRTR1 (0.43) HCRTR1HCRTR2TNFKCNK3KCNK9
SCHEMBL4693718 0.89 TSHR (0.38) HCRTR1HCRTR2HPGDTNFDPP4
SCHEMBL4691904 0.88 HCRTR1 (0.46) HCRTR1HCRTR2USP2TNFKCNK3
SCHEMBL4694763 0.88 HCRTR1 (0.37) HCRTR1HCRTR2TNFDPP4DPP8
SCHEMBL4694083 0.88 TSHR (0.40) HCRTR1HCRTR2HPGDTNFDPP4
SCHEMBL4690680 0.88 HCRTR1 (0.42) HCRTR1HCRTR2HPGDTNFP2RX7
SCHEMBL4692703 0.87 HCRTR1 (0.48) HCRTR1HCRTR2TNFKCNK3KCNK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1761542-B1 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS HOFFMANN LA ROCHE (CH) 2008-01-02 EP claimed
EP-1761542-B1 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS HOFFMANN LA ROCHE (CH) 2008-01-02 EP disclosed